2026 NPPES data Oncology Pharmacist NPI 1346567443 RAMESH NEERPAT
Verify on CMS →

Ramesh Neerpat, RAMESH NEERPAT

Oncology Pharmacist in Tamarac, Florida.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,699 in Oncology Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
152
Medicare Part D claims · 136 beneficiaries · Oncology Pharmacist avg: 160
Generic prescribing
0%
generic claims · 100% brand-name · higher generic rates reduce patient out-of-pocket costs
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Ramesh Neerpat, RAMESH NEERPAT filed 152 Medicare Part D claims in 2023 as a Oncology Pharmacist in Tamarac, Florida, prescribing 0% generic.

152
Part D claims, 2023
0%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Ramesh Neerpat, RAMESH NEERPAT's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

152 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about Ramesh Neerpat, RAMESH NEERPAT?

Quality data not reported

NPI registry status

Active

Issued 04/28/2010

NPI 1346567443

Primary specialty

Oncology Pharmacist

Niche

1,699 US NPIs in this specialty

Medicare Part D claims

152 5% vs specialty avg

2023 prescription claims

Specialty avg: 160

Specialty distribution in Florida

How Oncology Pharmacist compares to other specialties among Florida providers

Florida providers
Behavior Technician - 16.1%Behavior Technician16.1%Mental Health Counselor - 4.8%Mental Health Counselor4.8%Family Nurse Practitioner - 4.5%Family Nurse Practitioner4.5%Pharmacist - 4.2%Pharmacist4.2%Student in an Organized Health Care Education/Training Program - 3.8%Student in an Organized Health Care Education/Training Program3.8%Physical Therapist - 3.1%Physical Therapist3.1%Oncology Pharmacist - 0%Oncology Pharmacist0%
Largest specialties in Florida (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Oncology Pharmacist. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Ramesh Neerpat, RAMESH NEERPAT appears in the CMS NPPES registry as a Oncology Pharmacist provider holding RAMESH NEERPAT credentials at 7727 NW 79TH ST, Tamarac, FL, 33321, with a listed phone of (954) 597-1777. NPI 1346567443 was issued on 04/28/2010.

Medicare Part D records for calendar year 2023 show 152 prescription claims written by this provider, covering 136 Medicare beneficiaries and totaling roughly $33K in drug spend, split 100% brand-name and 0% generic by claim count.

Oncology Pharmacist is a narrow specialty nationwide, with 1,699 enrolled providers across 50 states and an average of 160 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

7727 NW 79TH ST
Tamarac, FL 33321

Provider Details

NPI 1346567443
Specialty Oncology Pharmacist
Credentials RAMESH NEERPAT
Gender Male
NPI Issued 04/28/2010

License & disciplinary context - Florida FLDOH 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Ramesh Neerpat, RAMESH NEERPAT. To verify Ramesh Neerpat, RAMESH NEERPAT's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

Ramesh Neerpat, RAMESH NEERPAT - brand share 100.0%
Oncology Pharmacist average

100% brand-name claims vs 0% generic, on 152 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

152
Total Claims
$33K
Total Drug Cost
136
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
152
Total Day Supply
152
Brand vs Generic
100% brand / 0% generic
Brand Drug Cost
$33K
Generic Drug Cost
$0

Patient Demographics

Average Patient Age
73.3 years
Avg HCC Risk Score
1.00
Gender Split
52% female / 48% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Shingrix
Varicella-Zoster Ge/As01b/Pf
63
Arexvy
Rsvpref3 Antigen/As01e/Pf
51
Boostrix Tdap
"Diphth
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oncology Pharmacist Overview

How Ramesh Neerpat, RAMESH NEERPAT fits within the Oncology Pharmacist landscape nationally.

1,699
Oncology Pharmacist Providers in US
50
States with Oncology Pharmacist
160
Avg Claims per Provider

Ramesh Neerpat, RAMESH NEERPAT's 152 claims are below the specialty average of 160.

Nearby Oncology Pharmacist Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Neerpat.

Compare Oncology Pharmacist nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Florida medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Oncology Pharmacist peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Ramesh Neerpat, RAMESH NEERPAT's specialty?
Ramesh Neerpat, RAMESH NEERPAT specializes in Oncology Pharmacist and practices in Tamarac, Florida. Credentials: RAMESH NEERPAT.
How much does Ramesh Neerpat, RAMESH NEERPAT prescribe under Medicare Part D?
In 2023, Ramesh Neerpat, RAMESH NEERPAT wrote 152 Medicare Part D claims totaling $33K in drug costs for 136 beneficiaries.
Where is Ramesh Neerpat, RAMESH NEERPAT located?
Ramesh Neerpat, RAMESH NEERPAT is located at 7727 NW 79TH ST, Tamarac, FL, 33321. Phone: (954) 597-1777.
What is Ramesh Neerpat, RAMESH NEERPAT's NPI number?
Ramesh Neerpat, RAMESH NEERPAT's National Provider Identifier (NPI) is 1346567443, issued on 04/28/2010.
Does Ramesh Neerpat, RAMESH NEERPAT prescribe more brand-name or generic drugs?
Ramesh Neerpat, RAMESH NEERPAT's prescribing is 100% brand-name and 0% generic drugs by claim count, with $33K in brand drug costs.
How many Oncology Pharmacist providers are there in the US?
There are 1,699 Oncology Pharmacist providers across 50 states in the US. The average Oncology Pharmacist provider writes 160 Medicare Part D claims per year.
What drugs does Ramesh Neerpat, RAMESH NEERPAT prescribe most often?
Based on 2023 Medicare Part D data, Ramesh Neerpat, RAMESH NEERPAT's most frequently prescribed drugs include Shingrix, Arexvy, Boostrix Tdap. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ramesh Neerpat, RAMESH NEERPAT accept Medicare?
Ramesh Neerpat, RAMESH NEERPAT appears in CMS Medicare data with 152 Part D claims and 136 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ramesh Neerpat, RAMESH NEERPAT's credentials?
Ramesh Neerpat, RAMESH NEERPAT's NPI is 1346567443 with credentials RAMESH NEERPAT. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.